Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer

被引：0
|
作者：
Makoto Natsume
Takaya Shimura
Hiroyasu Iwasaki
Yusuke Okuda
Mika Kitagawa
Yasuyuki Okamoto
Kazuki Hayashi
Hiromi Kataoka
机构：
[1] Nagoya City University Graduate School of Medical Sciences,Department of Gastroenterology and Metabolism
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Angiogenesis; Biomarker; Gastric cancer; PlGF; Ramucirumab; VEGF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1037 / 1046
页数：9
相关论文
共 50 条
  • [21] Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis
    Ishikawa, Masashi
    Iwasa, Satoru
    Nagashima, Kengo
    Aoki, Masahiko
    Imazeki, Hiroshi
    Hirano, Hidekazu
    Shoji, Hirokazu
    Honma, Yoshitaka
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Saruta, Masayuki
    Boku, Narikazu
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (02) : 533 - 540
  • [22] Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis
    Masashi Ishikawa
    Satoru Iwasa
    Kengo Nagashima
    Masahiko Aoki
    Hiroshi Imazeki
    Hidekazu Hirano
    Hirokazu Shoji
    Yoshitaka Honma
    Natsuko Okita
    Atsuo Takashima
    Ken Kato
    Masayuki Saruta
    Narikazu Boku
    Investigational New Drugs, 2020, 38 : 533 - 540
  • [23] Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer
    Myer, Nicole M.
    Shitara, Kohei
    Chung, Hyun C.
    Lordick, Florian
    Kelly, Ronan J.
    Szabo, Zsolt
    Cao, Z. Alexander
    Leong, Stephen
    Ilson, David H.
    Weichert, Wilko
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (08) : 2023 - 2043
  • [24] Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer
    Myer, Nicole M.
    Shitara, Kohei
    Chung, Hyun C.
    Lordick, Florian
    Kelly, Ronan J.
    Szabo, Zsolt
    Cao, Z. Alexander
    Leong, Stephen
    Ilson, David H.
    Weichert, Wilko
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (08) : 2023 - 2043
  • [25] The Vascular Endothelial Growth Factor-A121/Vascular Endothelial Growth Factor-A165 Ratio as a Predictor of the Therapeutic Response to Immune Checkpoint Inhibitors in Gastric Cancer
    Hamada, Yuki
    Tanoue, Kiyonori
    Arigami, Takaaki
    Yamakuchi, Munekazu
    Okawa, Masashi
    Matsushita, Daisuke
    Takenouchi, Kazunori
    Yamada, Shingo
    Maywar, Drew N.
    Nakayama, Chieri
    Oyama, Yoko
    Higashi, Sadayuki
    Fujisaki, Chieko
    Hozaka, Yuto
    Kita, Yoshiaki
    Hashiguchi, Teruto
    Ohtsuka, Takao
    CANCERS, 2024, 16 (23)
  • [26] Placental growth factor in cancer
    Dewerchin, Mieke
    Carmeliet, Peter
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (11) : 1339 - 1354
  • [27] 15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer
    Hu, Min
    Li, Kai
    Maskey, Ninu
    Xu, Zhigao
    Peng, ChunWei
    Tian, Sufang
    Li, Yan
    Yang, Guifang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 6910 - 6918
  • [28] Is ramucirumab still the only second-line treatment in metastatic gastric cancer?
    El Gharib, Khalil
    Kourie, Hampig Raphael
    PHARMACOGENOMICS, 2020, 21 (17) : 1203 - 1206
  • [29] Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices
    A. Scott Paulson
    Lisa M. Hess
    Astra M. Liepa
    Zhanglin Lin Cui
    Kathleen M. Aguilar
    Jamyia Clark
    William Schelman
    Gastric Cancer, 2018, 21 : 831 - 844
  • [30] Vascular Endothelial Growth Factor A Inhibition in Gastric Cancer
    Park, Do Joong
    Thomas, Nicholas J.
    Yoon, Changhwan
    Yoon, Sam S.
    GASTRIC CANCER, 2015, 18 (01) : 33 - 42
12345